Posted by Michael Wonder on 17 Mar 2022
COVID-19 vaccine weekly safety report (17 March 2022)
17 March 2022 - To 13 March 2022, the TGA has received 457 reports which have been assessed as likely to be myocarditis from about 37.4 million doses of Comirnaty (Pfizer) and 65 reports which have been assessed as likely to be myocarditis from about 3.9 million doses of Spikevax (Moderna).
No new cases of vaccine related thrombosis with thrombocytopenia syndrome have been reported this year.
